A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of Paclitaxel Injection Concentrate for Nano-Dispersion (PICN) Versus Investigators Choice (IC) in Subjects With Advanced Biliary Tract Cancer (BTC)
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 26 Oct 2016
At a glance
- Drugs Paclitaxel (Primary)
- Indications Biliary cancer
- Focus Registrational; Therapeutic Use
- Sponsors Sun Pharma Advanced Research Company
- 20 Oct 2016 Planned End Date changed from 1 Nov 2019 to 1 Dec 2019.
- 20 Oct 2016 Planned primary completion date changed from 1 Oct 2019 to 1 Dec 2019.
- 20 Oct 2016 Planned initiation date changed from 1 Apr 2016 to 1 Dec 2016.